International Stem Cell Corporation filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, BDO LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0995 USD | +62.58% | +39.75% | +60.48% |
1st Jan change | Capi. | |
---|---|---|
+60.48% | 796K | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ISCO Stock
- News International Stem Cell Corporation
- International Stem Cell Corporation Auditor Raises 'Going Concern' Doubt